Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Journal of Microbiology and Related Research

Volume  8, Issue 1, January-June 2022, Pages 13-15
 

Original Article

Severe Plasmodium Falciparum Malaria and Severe Plasmodium Vivax Malaria Treatment in India

Arvind Nath

Scientist 'E', National Institute of Malaria Research, New Delhi 110077, India.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/jmrr.2395.6623.8122.2

Abstract

Background: The treatment of severe P. falciparum Malaria and severe P. vivax Malaria is identical. Their treatment in India is complex because different regimes exist for the North-eastern part of the country and for the rest of the country. Also, different drugs are needed for the treatment of pregnant patients. oBjectives: To find out what are the antimalarials prescribed in India for treating severe Falciparum Malaria and severe Vivax Malaria. Methods: By reviewing documents prepared by NVBDCP. results: It is found that different regimes exist for treating severe Falciparum Malaria and severe Vivax Malaria depending on where the patient comes from, and the drugs differ based on the pregnancy status of the female patient. conclusions: More education is required among health care providers on how to treat severe P. falciparum Malaria and severe P. vivax Malaria. This paper addresses this concern


Corresponding Author : Arvind Nath